Codexis, Inc. (CDXS)
$1.41+0.00%Close
SELLRECOVERY · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $128M
- Beta
- 2.53
- P/E (TTM)
- -4.05
- Short % float
- 6.59%
- Days to cover
- 5.0
- SI change
- +20.2%
- 1W
- +1.44%
- 1M
- -4.08%
- vs SPY 1W
- +1.02%
- vs SPY 1M
- -6.14%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CDXS?
- LOPJLB’s latest quantitative signal on Codexis, Inc. (CDXS) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CDXS in?
- Codexis, Inc. (CDXS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Codexis, Inc. (CDXS) do?
- Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chem…